Graft-infiltrating cells expressing a CD200 transgene prolong allogeneic skin graft survival in association with local increases in Foxp3 +Treg and mast cells

Transplant Immunology

Volumn 25, Issue 4, 2011, Pages 187-193

  Gorczynski, Reginald M ^a,b   Chen, Zhiqi ^a   Khatri, Ismat ^a   Yu, Kai ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

CD200; Immunosuppression; Mast cells; Tolerance induction

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD200 TRANSGENE; CELL COUNT; CELL EXPANSION; CELL FUNCTION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FOXP3+ REGULATORY T LYMPHOCYTE; GENE OVEREXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOLOGY; IN VITRO STUDY; LYMPH NODE CELL; MALE; MAST CELL; MAST CELL DEGRANULATION; MIXED LEUKOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SKIN ALLOGRAFT; T LYMPHOCYTE ACTIVATION; TRANSGENE; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIGENS, CD; CELL DEGRANULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; LYMPHOCYTE ACTIVATION; MALE; MAST CELLS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 80054052699     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.07.006     Document Type: Article

References (37)

1. Morelli A.E., Thomson A.W. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 2003, 196:125-146.
2. Min W.P., Zhou D., Ichim T.E. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003, 170:1304-1312.
3. Chen Z., Zeng H., Gorczynski R.M. Cloning and characterization of the murine homologue of the rat/human MRC OX-2 gene. Bba Mol Basis Dis 1997, 1362:6-10.
4. Gorczynski R.M., Chen Z., Fu X.M., Zeng H. Increased expression of the novel molecule Ox-2 is involved in prolongation of murine renal allograft survival. Transplantation 1998, 65:1106-1114.
5. Gorczynski R.M., Cattral M.S., Chen Z.G. An immunoadhesin incorporating the molecule OX-2 is a potent immunosuppressant that prolongs allo- and xenograft survival. J Immunol 1999, 163:1654-1660.
6. Kai G., Chen Z., Yang S., Gorczynski R.M. Decreased alloreactivity using donor cells from mice expressing a CD200 transgene under control of a tetracycline-inducible promoter. Transplantation 2005, 80:394-401.
7. Gorczynski R., Chen Z.Q., Kai Y., Lee L., Wong S., Marsden P.A. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol 2004, 172:7744-7749.
8. Gorczynski R.M., Chen Z.Q., He W. Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol 2009, 183:1560-1568.
9. Matsui Y., Saiura A., Sugawara Y. Identification of gene expression profile in tolerizing murine cardiac allograft by costimulatory blockade. Physiol Genomics 2003, 15:199-208.
10. Caughey G.H., Schaumberg T.H., Zerweck E.H. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 1993, 15:614-620.
11. Lu L.F., Lind E.F., Gondek D.C. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442:997-1002.
12. Jahanyar J., Koerner M.M., Loebe M., Youker K.A., Torre-Amione G., Noon G.P. The role of mast cells after solid organ transplantation. Transplantation 2008, 85:1365-1371.
13. deVries V.C., Noelle R.J. Mast cell mediators in tolerance. Curr Opin Immunol 2010, 22:643-648.
14. Boerma M., Fiser W.P., Hoyt G. Influence of mast cells on outcome after heterotopic cardiac transplantation in rats. Transpl Int 2006, 20:256-265.
15. Li Q.Y., Raza-Ahmad A., MacAulay M.A., et al. The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts. Transplantation 1992, 53:1047-1051.
16. Chen Z., Chen D.-X., Yu K.P., Lamptey B., Gorczynski R.M. Identification of an expressed truncated form of CD200, CD200tr, which is a physiologic antagonist of CD200-induced suppression. Transplantation 2008, 86:1116-1124.
17. Szabo A., Boros M., Kaszaki J., Nagy S. The role of mast cells in mucosal permeability changes during ischemia-reperfusion injury of the small intestine. Shock 1997, 8:284-291.
18. Kolaczkowska E., Seljelid R., Barbara Plytycz B. Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J Leukocyte Biol 2001, 69:33-42.
19. Abonia J.P., Friend D.S., Austen W.G. Mast cell protease 5 medaites ischemia-reperfusion injury of mouse skeletal muscle. J Immunol 2005, 174:7285-7291.
20. deVries V.C., Elgueta R., Lee D.M., Noelle R.J. Mast cell protease 6 is required for allograft tolerance. Transplant Proc 2010, 42:2759-2762.
21. Stassen M., Arnold M., Hültner L. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol 2000, 164:5549-5555.
22. Boudakov I., Liu J., Fan N., Gulay P., Wong K., Gorczynski R.M. Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200. Transplantation 2007, 84:251-257.
23. Wan Y.S.Y., Flavell R.A. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 2006, 212:114-130.
24. Campbell D.J., Koch M.A. Phenotypic and functional specilaization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011, 11:119-130.
25. Cobbold S.P. The hidden truth about gene expression in Tregs: is it what you don't see that counts?. Eur J Immunol 2006, 36:1360-1363.
26. Alegre M.L., Florquin S., Goldman M. Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol 2007, 19:563-568.
27. Sayed B.A., AC, MRQ, MA.B The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008, 26:705-739.
28. de Vries V.C., Noelle R.J. Mast cell mediators in tolerance. Curr Opin Immunol 2010, 22:643-648.
29. Veldhoen M., Uyttenhove C., van Snick J. Transforming growth factor-b 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008, 9:1341-1346.
30. Elyaman W., Bradshaw E.M., Uyttenhove C. IL-9 induces differentiation of T(H)17 cells and enhances function of FoxP3(+) natural regulatory T cells. Proc Nat Acad Sci USA 2009, 106:12885-12890.
31. de Vries V.C., Wasiuk A., Bennett K.A. Mast cell degranulation breaks peripheral tolerance. Am J Transplantation 2009, 9:2270-2280.
32. Sembeil R., Sanhadji K., Vivier G., Chargui J., Touraine J.L. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene. Transpl Immunol 2004, 13:1-8.
33. Nakae S., Iikura M., Suto H. TIM-1 and TIM-3 enhancement of Th2 cytokine poduction by mast cells. Blood 2007, 110:2565-2568.
34. FrisanchoKiss S., Nyland J.F., Davis S.E. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 2006, 176:6411-6415.
35. Sugerman P.B., Faber S.B., Willis L.M. Kinetics of gene expression in murine cutaneous graft-versus-host disease. Amer J Pathol 2004, 164:2189-2202.
36. Miyazaki D., TN, MT, KW, C-C, RMR, SJ.O Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest 2005, 115:434-442.
37. Zhang S.L., Cherwinski H., Sedgwick J.D., Phillips J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol 2004, 173:6786-6793.